Knight Therapeutics, Inc. (GUD.TO)
9.89
+0.23
(+2.38%)
CAD |
TSX |
Aug 25, 11:17
Knight Therapeutics Market Cap : 971.43M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 948.84M |
| August 21, 2026 | 948.84M |
| August 20, 2026 | 945.89M |
| August 19, 2026 | 964.56M |
| August 18, 2026 | 955.72M |
| August 17, 2026 | 960.63M |
| August 14, 2026 | 915.44M |
| August 13, 2026 | 904.64M |
| August 12, 2026 | 912.50M |
| August 11, 2026 | 933.12M |
| August 10, 2026 | 914.46M |
| August 07, 2026 | 958.66M |
| August 06, 2026 | 933.12M |
| August 05, 2026 | 909.55M |
| August 04, 2026 | 917.41M |
| July 31, 2026 | 966.80M |
| July 30, 2026 | 959.92M |
| July 29, 2026 | 969.74M |
| July 28, 2026 | 966.80M |
| July 27, 2026 | 964.83M |
| July 24, 2026 | 955.99M |
| July 23, 2026 | 952.06M |
| July 21, 2026 | 979.57M |
| July 20, 2026 | 966.80M |
| July 17, 2026 | 964.83M |
| Date | Value |
|---|---|
| July 16, 2026 | 952.06M |
| July 15, 2026 | 955.01M |
| July 14, 2026 | 962.87M |
| July 13, 2026 | 962.87M |
| July 10, 2026 | 962.87M |
| July 09, 2026 | 989.39M |
| July 08, 2026 | 982.52M |
| July 07, 2026 | 978.59M |
| July 06, 2026 | 981.53M |
| July 03, 2026 | 973.67M |
| July 02, 2026 | 966.80M |
| June 30, 2026 | 967.78M |
| June 29, 2026 | 953.04M |
| June 26, 2026 | 928.48M |
| June 25, 2026 | 920.62M |
| June 24, 2026 | 918.65M |
| June 23, 2026 | 906.86M |
| June 22, 2026 | 914.72M |
| June 19, 2026 | 910.79M |
| June 18, 2026 | 915.71M |
| June 17, 2026 | 914.72M |
| June 16, 2026 | 912.76M |
| June 15, 2026 | 931.43M |
| June 12, 2026 | 931.43M |
| June 11, 2026 | 921.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| HLS Therapeutics, Inc. | 118.20M |
| Bausch Health Cos., Inc. | 3.354B |
| Cipher Pharmaceuticals, Inc. | 359.88M |
| BioSyent, Inc. | 178.50M |
| Revive Therapeutics Ltd. | 10.89M |
Market Cap Related Metrics
| PE Ratio | 65.85 |
| PS Ratio | 1.789 |
| PEG Ratio | 0.0143 |
| Price to Book Value | 1.216 |
| Price to Free Cash Flow | 9.894 |
| Price | 9.89 |
| Earnings Yield | 1.52% |
| PEGY Ratio | 0.0143 |
| Operating PE Ratio | 37.09 |
| Normalized PE Ratio | 48.82 |